Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Buy
63
BDX Quote, Financials, Valuation and Earnings
Last price:
$202.69
Seasonality move
:
3.89%
Day range:
$201.40 - $206.37
52-week range:
$162.29 - $251.99
Dividend yield:
2.06%
P/E ratio:
34.78x
P/S ratio:
2.67x
P/B ratio:
2.28x
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
-13.51%
Market cap:
$57.9B
Revenue:
$21.8B
EPS (TTM):
$5.83
Analysts' Opinion
-
Consensus RatingBecton, Dickinson & Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $206.67, Becton, Dickinson & Co. has an estimated upside of 1.93% from its current price of $202.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $183.00 representing 100% downside risk from its current price of $202.75.
Fair Value
-
According to the consensus of 12 analysts, Becton, Dickinson & Co. has 1.93% upside to fair value with a price target of $206.67 per share.
BDX vs. S&P 500
-
Over the past 5 trading days, Becton, Dickinson & Co. has overperformed the S&P 500 by 2.4% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Becton, Dickinson & Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Becton, Dickinson & Co. has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Becton, Dickinson & Co. reported revenues of $5.9B.
Earnings Growth
-
Becton, Dickinson & Co. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Becton, Dickinson & Co. reported earnings per share of $1.72.
Enterprise value:
77B
EV / Invested capital:
--
Price / LTM sales:
2.67x
EV / EBIT:
24.98x
EV / Revenue:
3.53x
PEG ratio (5yr expected):
2.22x
EV / Free cash flow:
28.85x
Price / Operating cash flow:
21.88x
Enterprise value / EBITDA:
14.27x
Gross Profit (TTM):
$9.9B
Return On Assets:
3.03%
Net Income Margin (TTM):
7.68%
Return On Equity:
6.6%
Return On Invested Capital:
3.72%
Operating Margin:
14.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $19.4B | $20.2B | $21.8B | $5.4B | $5.9B | |
| Gross Profit | $8.2B | $9.2B | $9.9B | $2.5B | $2.8B | |
| Operating Income | $2.4B | $2.9B | $3.1B | $820M | $881M | |
| EBITDA | $4.6B | $5B | $5.4B | $1.3B | $1.4B | |
| Diluted EPS | $4.97 | $5.94 | $5.83 | $1.45 | $1.72 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.8B | $8.1B | $8.7B | $10.5B | $9.3B | |
| Total Assets | $53.9B | $52.9B | $52.8B | $57.3B | $55.3B | |
| Current Liabilities | $6.6B | $7.8B | $6.6B | $9B | $8.3B | |
| Total Liabilities | $30.2B | $27.7B | $27B | $31.4B | $29.9B | |
| Total Equity | $23.7B | $25.3B | $25.8B | $25.9B | $25.4B | |
| Total Debt | $18B | $16.4B | $16.3B | $20.8B | $19.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3B | $3.8B | $3.4B | $1.2B | $1.4B | |
| Cash From Investing | -$716M | -$5.5B | -$818M | -$3.9B | -$494M | |
| Cash From Financing | -$2B | $2.1B | -$3.6B | $124M | -$809M | |
| Free Cash Flow | $2.1B | $3.1B | $2.7B | $882M | $1B | |
BDX
Sector
Market Cap
$57.9B
$28.3M
Price % of 52-Week High
80.46%
51.99%
Dividend Yield
2.06%
0%
Shareholder Yield
3.83%
-1.59%
1-Year Price Total Return
-13.51%
-17.41%
Beta (5-Year)
0.236
0.495
Dividend yield:
2.06%
Annualized payout:
$4.16
Payout ratio:
60.57%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$199.95
200-day SMA
Buy
Level
$187.79
Bollinger Bands (100)
Buy
Level
184.83 - 196.99
Chaikin Money Flow
Buy
Level
650.7M
20-day SMA
Buy
Level
$198.15
Relative Strength Index (RSI14)
Buy
Level
60.44
ADX Line
Buy
Level
18.17
Williams %R
Neutral
Level
-29.2212
50-day SMA
Buy
Level
$192.22
MACD (12, 26)
Buy
Level
2.64
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
316.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1081)
Buy
CA Score
(Annual)
Level (-0.2476)
Buy
Beneish M-Score
(Annual)
Level (-2.6391)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.0167)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Stock Forecast FAQ
In the current month, BDX has received 3 Buy ratings 9 Hold ratings, and 0 Sell ratings. The BDX average analyst price target in the past 3 months is $206.67.
-
Where Will Becton, Dickinson & Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Becton, Dickinson & Co. share price will rise to $206.67 per share over the next 12 months.
-
What Do Analysts Say About Becton, Dickinson & Co.?
Analysts are divided on their view about Becton, Dickinson & Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Becton, Dickinson & Co. is a Sell and believe this share price will drop from its current level to $183.00.
-
What Is Becton, Dickinson & Co.'s Price Target?
The price target for Becton, Dickinson & Co. over the next 1-year time period is forecast to be $206.67 according to 12 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is BDX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Becton, Dickinson & Co. is a Hold. 9 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BDX?
You can purchase shares of Becton, Dickinson & Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Becton, Dickinson & Co. shares.
-
What Is The Becton, Dickinson & Co. Share Price Today?
Becton, Dickinson & Co. was last trading at $202.69 per share. This represents the most recent stock quote for Becton, Dickinson & Co.. Yesterday, Becton, Dickinson & Co. closed at $202.75 per share.
-
How To Buy Becton, Dickinson & Co. Stock Online?
In order to purchase Becton, Dickinson & Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BDX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BDX
Sector
P/E ratio
34.78x
24.24x
PEG ratio
2.22x
-0.01x
P/B ratio
2.28x
1.84x
Price / LTM sales
2.67x
1.60x
Growth Metrics
BDX
Sector
Revenue growth
8.33%
4.6%
Earnings growth
18.53%
10.71%
Revenue (5-year growth)
6.32%
6.45%
Earnings forecast
$2.81
-$0.19
Profitability
BDX
Sector
Profitability FY 2025
$9.9B
$3.5M
Return on invested capital
3.72%
-32.04%
Return on assets
3.03%
-28.44%
Return on equity
6.6%
-38.09%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Feb
5
Balance Sheet
BDX
Sector
Total cash
$859M
$26.1M
Short term investments
$445M
$25.7M
Total assets
$55.3B
$76.4M
Long term debt
$19.9B
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
